Financial Gravity Asset Management, Inc. Gilead Sciences, Inc. Transaction History

Financial Gravity Asset Management, Inc.

$400 Billion
Q2 2024

A detailed history of Financial Gravity Asset Management, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Financial Gravity Asset Management, Inc. holds 228 shares of GILD stock, worth $21,525. This represents 0.0% of its overall portfolio holdings.

Number of Shares

228

Previous 235 2.98%

Holding current value

$21,525

Previous $18.9 Million 17.44%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$63.15 - $72.88 $442 - $510	-7 Reduced 2.98%	228 $15.6 Million
Q1 2024 Jun 26, 2024	SELL	$71.58 - $87.29 $715 - $872	-10 Reduced 4.08%	235 $18.9 Million
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $271,073 - $330,567	-3,787 Reduced 91.72%	342 $25.1 Million
Q4 2023 Jun 26, 2024	SELL	$73.27 - $83.09 $7,107 - $8,059	-97 Reduced 28.36%	245 $19.9 Million
Q3 2023 Nov 15, 2023	BUY	$73.94 - $80.67 $284,151 - $310,014	3,843 Added 1343.71%	4,129 $309,000
Q2 2023 Aug 08, 2023	BUY	$76.01 - $86.7 $988 - $1,127	13 Added 4.76%	286 $7.12 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $14,456 - $16,470	187 Added 217.44%	273 $4.26 Million
Q4 2022 Feb 15, 2023	SELL	$62.32 - $89.47 $41,006 - $58,871	-658 Reduced 88.44%	86 $7.22 Million
Q3 2022 Nov 03, 2022	SELL	$59.54 - $68.01 $33,223 - $37,949	-558 Reduced 42.86%	744 $1.49 Million
Q2 2022 Aug 05, 2022	SELL	$57.72 - $65.01 $64,473 - $72,616	-1,117 Reduced 46.18%	1,302 $1.49 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $67,071 - $84,047	-1,158 Reduced 32.37%	2,419 $3.97 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $222,603 - $252,658	3,431 Added 2350.0%	3,577 $10.5 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $676 - $730	-10 Reduced 6.41%	146 $70,000
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $1,840 - $2,011	-29 Reduced 15.68%	156 $69,000
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $900 - $1,026	15 Added 8.82%	185 $12 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $9,630 - $10,973	170 New	170 $9,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $94,331 - $109,536	-1,304 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $25,615 - $32,809	-409 Reduced 23.88%	1,304 $97,000
Q4 2019 Feb 28, 2020	SELL	$61.62 - $67.78 $34,630 - $38,092	-562 Reduced 24.7%	1,713 $73,000
Q3 2019 Oct 15, 2019	SELL	$62.51 - $69.0 $76,762 - $84,732	-1,228 Reduced 35.06%	2,275 $144,000
Q2 2019 Jul 26, 2019	SELL	$61.87 - $69.38 $39,101 - $43,848	-632 Reduced 15.28%	3,503 $237,000
Q1 2019 Apr 19, 2019	SELL	$62.53 - $70.05 $49,898 - $55,899	-798 Reduced 16.18%	4,135 $272,000
Q3 2018 Oct 31, 2018	SELL	$71.28 - $78.92 $55,527 - $61,478	-779 Reduced 13.64%	4,933 $350,000
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $6,228 - $7,265	96 Added 1.71%	5,712 $438,000
Q1 2018 May 23, 2018	BUY	$72.84 - $88.8 $409,069 - $498,700	5,616 New	5,616 $375,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.

Account

Financial Gravity Asset Management, Inc. Gilead Sciences, Inc. Transaction History